1,630
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

Analysis of regulatory effect of miR-149-5p on Sphingosine-1-phosphate receptor 2 of pericytes and its neuroprotective molecular mechanism after acute cerebral ischemia reperfusion in rats

, , , , , , , , & show all
Pages 3348-3357 | Received 14 Jan 2021, Accepted 19 Jun 2021, Published online: 05 Jul 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yaoping Yu, Meng Wang, Xiao Yu, Yi Yan, Bo Yu & Dayin Zhang. (2022) Targeting Forkhead box O1-aquaporin 5 axis mitigates neuropathic pain in a CCI rat model through inhibiting astrocytic and microglial activation. Bioengineered 13:4, pages 8567-8580.
Read now

Articles from other publishers (4)

Chengzhao Liu, Kedi Liu, Xingru Tao, Weihong Li, Shi Zhao, Qi Dai, Hong Yao, Fei Mu, Sha Chen, Jing Li, Taiwei Dong, Jialin Duan, Peifeng Wei, Feng Gao & Miaomiao Xi. (2024) Pharmacodynamics and mechanism of Erigeron breviscapus granules in the treatment of ischemic stroke in mice by regulating sphingolipid metabolism based on metabolomics. Journal of Pharmaceutical and Biomedical Analysis 242, pages 116058.
Crossref
Jingfei Xue, Jicheng Lin, Zhe Liu, Qi Zhang, Jiahui Tang, Jiaxu Han, Siting Wu, Canying Liu, Ling Zhao, Yiqing Li & Yehong Zhuo. (2023) Alleviating early demyelination in ischaemia/reperfusion by inhibiting sphingosine‐1‐phosphate receptor 2 could protect visual function from impairment. Brain Pathology 33:5.
Crossref
Zhuo Zhang, Agnes Schäfer, Benjamin Voellger, Jun-wen Wang, Ting Lei, Christopher Nimsky & Jörg W. Bartsch. (2022) MicroRNA-149 Regulates Proliferation, Migration, and Invasion of Pituitary Adenoma Cells by Targeting ADAM12 and MMP14. Current Medical Science 42:6, pages 1131-1139.
Crossref
Aili Sun, Kinga G. Blecharz-Lang, Andrzej Małecki, Patrick Meybohm, Marta M. Nowacka-Chmielewska & Malgorzata Burek. (2022) Role of microRNAs in the regulation of blood-brain barrier function in ischemic stroke and under hypoxic conditions in vitro. Frontiers in Drug Delivery 2.
Crossref